Qiagen N.V. (QGEN) Evercore 8th Annual Healthcare Conference December 3, 2025 10:50 AM EST
Company Participants
Roland Sackers – CFO, MD & Member of Management Board
John Gilardi – VP & Head of Corporate Communications
Daniel Wendorff – VP & Head of Investor Relations
Conference Call Participants
Vijay Kumar – Evercore ISI Institutional Equities, Research Division
Presentation
Vijay Kumar
Evercore ISI Institutional Equities, Research Division
Thanks, everyone, for joining us this morning. A pleasure to have with us QIAGEN. We have the CFO, Roland Sackers. From Investor Relations, we have Daniel Wendorff. And we have John Gilardi, VP of Communications.
Question-and-Answer Session
Vijay Kumar
Evercore ISI Institutional Equities, Research Division
I guess, Roland, for me, when I looked at the numbers, your organic has been the best-in-class, right, in Life Science Tools. It’s been a challenging year. I know historically, QIAGEN — when I think of QIAGEN, NIH and government academia comes to mind, I mean, despite those challenges, like you guys have done phenomenally well this year, well above your Life Science Tools peers. So when you just do a review of the year, right, what has surprised you? And what do you attribute this above peer performance to?
Roland Sackers
CFO, MD & Member of Management Board
Yes. First of all, thanks for having us. And again, it’s a pleasure to be here and finally also have good microphones. So I think you congratulate you that. I’ve seen that differently in other conferences. But again, what is important is, and I think it’s fair to say that we had a really good start of the year with a 7% growth rate in the first quarter and also the second and third quarter with a 6% overall growth rate was actually, I think, well received by the market as well.
Read the full article here